Lassa Fever
Cross-source consensus on Lassa Fever from 1 sources and 4 claims.
1 sources · 4 claims
Evidence quality
Where it comes from
Highlighted claims
- Lassa fever is an acute febrile illness caused by Lassa virus that can progress to severe disease with substantial mortality. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
- Lassa fever transmission mainly occurs from the rodent reservoir Mastomys natalensis, while human-to-human transmission most often occurs in healthcare settings. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
- Nigeria carries the highest Lassa fever burden in West Africa, especially in Edo and Ondo states. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
- There are no approved vaccines for Lassa fever, although an rVSV-LASV-GPC vaccine has shown promising early results. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial